{
  "compound": "CBD + MTX vs MTX alone",
  "condition": "ARTHRITIS",
  "effect_size": "Large (RR = 1.58, 95% CI: 1.29-1.93)",
  "study_type": "RCT",
  "source": "NORML:ARTHRITIS_RCT_008",
  "participants": "204 adults with early RA (<2 years duration, MTX-naive)",
  "year": 2021,
  "notes": "Cannabidiol Adjunctive to Methotrexate in Early Rheumatoid Arthritis: RCT",
  "confidence": "medium",
  "abstract": "CBD+MTX: 68% achieved ACR50 vs MTX alone: 43%; p<0.001; DAS28-CRP remission: 52% vs 29%"
}